Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Post-operative Nausea and Vomiting (PONV) Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026

Report Description

Post-operative Nausea and Vomiting (PONV) Market - Overview

This report studies the current as well as future prospects of the global post-operative nausea and vomiting (PONV) market. Stakeholders of the market include companies and intermediaries engaged in the manufacture, commercialization, and provision of drug therapies as well as devices for treatment, and new players planning to enter the market. The report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. The section also provides overall information and data analysis of the global post-operative nausea and vomiting (PONV) market with respect to the leading market segments based on treatment type, distribution channel, and region.

The global post-operative nausea and vomiting market has been segmented based on treatment type, distribution channel, and region. In terms of treatment type, the market has been classified into serotonin antagonists, steroids, dopamine antagonists, nk-1 receptor antagonists, others, and non-pharmacological treatment. Based on distribution channel, the global post-operative nausea and vomiting (PONV) market has been divided into hospital pharmacies, online pharmacies, and retail pharmacies and drug stores.

Each of the market segments has been extensively analyzed based on market-related factors such as increase in incidence rate of PONV in surgical patient population and rise in adoption rate of non-pharmacological methods of treatment. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the PONV market and is likely to influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors are expected to help market players take strategic decisions to strengthen their positions and enhance their shares in the global PONV market.

Geographically, the global PONV market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGR for the forecast period from 2018 to 2026, considering 2017 as the base year. The report provides market size and forecast for the major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the overview section. It also provides market attractiveness analysis and market share analysis of key players, thereby presenting a thorough examination of the overall competitive scenario of the global PONV market.

Major players operating in the global PONV market are Acacia Pharma, F. Hoffmann-La Roche AG, Novartis AG, Ani Pharmaceuticals, Inc., Camurus AB, Sanofi, Helsinn Holding S.A., Eisai Corporation, Merck and Co., and GlaxoSmithKline Corporation.

The global PONV market has been segmented as follows:

Global PONV Market, by Treatment Type

  • Serotonin Antagonists
  • Steroids
  • Dopamine Antagonists
  • NK-1 Receptor Antagonists
  • Others
  • Non-pharmacologic Treatment

Global PONV Market, by Application

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies and Drug Stores

Global PONV Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote